FERRACIN, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 8.694
AS - Asia 3.473
EU - Europa 2.298
SA - Sud America 553
AF - Africa 53
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.082
Nazione #
US - Stati Uniti d'America 8.541
SG - Singapore 1.453
CN - Cina 1.011
DE - Germania 492
BR - Brasile 461
UA - Ucraina 376
IT - Italia 361
HK - Hong Kong 327
TR - Turchia 281
GB - Regno Unito 267
FI - Finlandia 202
VN - Vietnam 156
PL - Polonia 145
SE - Svezia 132
RU - Federazione Russa 97
MX - Messico 72
CA - Canada 71
ID - Indonesia 63
AR - Argentina 45
NL - Olanda 42
IN - India 41
FR - Francia 40
AT - Austria 26
BE - Belgio 26
BD - Bangladesh 25
ES - Italia 24
JP - Giappone 23
ZA - Sudafrica 23
IQ - Iraq 21
RO - Romania 19
LT - Lituania 16
CZ - Repubblica Ceca 13
IR - Iran 11
CO - Colombia 10
EC - Ecuador 10
CL - Cile 9
KR - Corea 9
TN - Tunisia 7
EG - Egitto 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
PY - Paraguay 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AL - Albania 4
CH - Svizzera 4
JO - Giordania 4
LB - Libano 4
MY - Malesia 4
OM - Oman 4
VE - Venezuela 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EU - Europa 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
TW - Taiwan 3
UY - Uruguay 3
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
DK - Danimarca 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
LC - Santa Lucia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
Totale 15.082
Città #
Fairfield 1.070
Woodbridge 983
Ashburn 802
Singapore 748
Houston 605
Chandler 460
Jacksonville 436
Seattle 429
Ann Arbor 419
Santa Clara 377
Beijing 359
Wilmington 347
Cambridge 331
Hong Kong 320
Izmir 184
Munich 181
Los Angeles 152
Warsaw 141
Nanjing 126
Dallas 119
Ferrara 115
New York 100
Princeton 100
San Diego 89
Boardman 74
Helsinki 59
Milan 56
Jakarta 55
São Paulo 55
Shanghai 54
Ho Chi Minh City 53
Mexico City 47
Turku 46
London 43
Nanchang 42
Bremen 41
Falls Church 41
Dearborn 34
Chicago 33
Tianjin 32
Brooklyn 28
Hebei 28
Montreal 28
Hanoi 27
Brussels 26
Buffalo 26
Shenyang 26
Changsha 25
The Dalles 25
Toronto 24
Hefei 23
Jiaxing 23
Addison 21
Tokyo 20
Jinan 19
Johannesburg 19
Boston 18
Denver 18
Mountain View 18
Poplar 18
Stockholm 18
Falkenstein 17
Timisoara 17
Atlanta 16
Hangzhou 16
Nuremberg 16
Orem 16
Phoenix 16
Ankara 15
Frankfurt am Main 15
Rio de Janeiro 15
San Francisco 15
Moscow 14
Norwalk 14
Vienna 14
Bologna 13
Dong Ket 13
Kunming 13
Manchester 12
Washington 12
Amsterdam 11
Chennai 11
Columbus 11
Guangzhou 11
Ningbo 11
Philadelphia 11
Querétaro 11
Zhengzhou 11
Auburn Hills 10
Belo Horizonte 10
Redwood City 10
San Mateo 10
Tappahannock 10
Augusta 9
Brno 9
Curitiba 9
Naples 9
Rome 9
San Jose 9
Baghdad 8
Totale 10.715
Nome #
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 337
Absolute quantification of cell-free microRNAs in cancer patients 273
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 269
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 263
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 251
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 233
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 216
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 216
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 215
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 215
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 201
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines 197
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 196
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 191
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 190
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 188
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 187
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 183
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 182
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 181
A microRNA signature of hypoxia 180
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 177
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 174
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 172
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 171
Extensive modulation of a set of microRNAs in primary glioblastoma 165
Espressione dei MicroRNA nei carcinomi mammari 165
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 164
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 161
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 160
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 158
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 157
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 156
Tumor suppressor functions of ARLTS1 in lung cancers 156
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 156
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice 153
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 152
MicroRNA deregulation in human thyroid papillary carcinomas 151
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 149
Oncogenic role of miR-483-3p at the IGF2/483 locus 148
The Role of Micro-RNAs in Rheumatic Diseases: An Update 147
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 146
MicroRNAs in cancer (an overview) 144
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 144
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 140
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 140
Regulation of microRNA expression: the hypoxic component 139
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 139
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 139
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 139
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 137
Micro-RNA profiling in kidney and bladder cancers 136
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 136
Modulation of mismatch repair and genomic stability by miR-155 135
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 133
Principles of MicroRNA involvement in breast cancer 132
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 130
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 129
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 129
Mutated beta-catenin evades a microRNA-dependent regulatory loop 129
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 128
MicroRNAs and Their Role in Cancer 126
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 122
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 121
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 120
OncomiR detection in circulating body fluids: A PDMS microdevice perspective 120
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 119
A microRNA expression signature of human solid tumors defines cancer gene targets 118
Hemostasis gene expression of the internal jugular and saphenous veins 118
First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) 117
Micro-markers: microRNAs in cancer diagnosis and prognosis 115
MicroRNAs: toward the clinic for breast cancer patients 114
null 111
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 105
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells 105
MicroRNA coinvolti nello sviluppo del carcinoma epatocellulare. Identificazione delle proteine bersaglio. 102
null 101
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 100
null 96
null 94
null 94
null 93
null 91
Familial cancer associated with a polymorphism in ARLTS1 91
null 89
null 89
null 89
null 88
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 88
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 88
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 88
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 88
null 84
MiR-15a and miR-16-1 cluster functions in human leukemia 83
MicroRNA gene expression deregulation in human breast cancer 83
null 81
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas 80
null 80
Karyotype-specific microRNA signature in chronic lymphocytic leukemia 78
Totale 14.451
Categoria #
all - tutte 69.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.094
Totale 72.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021892 0 0 0 0 0 145 66 146 44 171 203 117
2021/20221.191 54 107 107 31 56 74 78 57 39 84 113 391
2022/20231.051 114 77 35 156 161 166 40 76 121 12 47 46
2023/2024561 70 63 23 8 43 111 27 35 10 22 9 140
2024/20252.571 43 46 181 121 316 251 118 143 482 238 362 270
2025/20263.251 673 211 522 842 887 116 0 0 0 0 0 0
Totale 15.266